ArticleTobacco induced diseases2025
Global, regional, and national temporal trends in mortality and disease burden of nasopharyngeal carcinoma attributable to smoking from 1990 to 2021 and predictions to 2040.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSmoking is a major environmental risk factor for nasopharyngeal carcinoma (NPC), but the global burden and epidemiological trends of NPC attributable to smoking remain unclear.
methodsData were obtained from the 2021 Global Burden of Disease study. A comprehensive analysis was conducted on mortality, years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life years (DALYs) attributable to NPC attributable to smoking. Clustering analysis was applied to evaluate the variation patterns across 21 regions. The NORDPRED age-period-cohort model was used for prediction.
resultsIn 2021, there were 13410 deaths globally from NPC attributable to smoking, 10031 YLDs, 1379583 YLLs, and 389614 DALYs. The disease burden was most severe in Asia. Males bore a significantly higher burden than females, mainly concentrated in middle-aged and older populations. From 1990 to 2021, although the number of cases increased, ASRs showed a marked decline, particularly among females and in regions with both high and low sociodemographic index (SDI) levels. Regional analyses revealed significant reductions of the disease burden in Australasia and Western Europe. The 21 regions were divided into 4 groups based on changes in mortality, representing distinct variation patterns. Projections from 2022 to 2040 indicate that, while the total number of deaths and disease burden is expected to rise, ASRs are anticipated to decline except YLDs.
conclusionsSmoking contributes significantly to the disease burden of NPC, posing a serious threat to public health. Targeted intervention strategies should be implemented according to the regional clustering results of disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.